EFFECTIVENESS OF 2 METHODS FOR INFORMING SCHIZOPHRENIC-PATIENTS ABOUT NEUROLEPTIC MEDICATION

被引：0
|
作者：
KLEINMAN, I
SCHACHTER, D
JEFFRIES, J
GOLDHAMER, P
机构：
[1] UNIV TORONTO,DEPT PSYCHIAT,TORONTO M5S 1A1,ONTARIO,CANADA
[2] CLARKE INST PSYCHIAT,TORONTO M5T 1R8,ONTARIO,CANADA
[3] MT SINAI HOSP,SCHIZOPHRENIA CLIN,TORONTO M5G 1X5,ONTARIO,CANADA
来源：
HOSPITAL AND COMMUNITY PSYCHIATRY | 1993年 / 44卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1189 / 1191
页数：3
相关论文
共 50 条
  • [41] NEUROLEPTIC WITHDRAWAL IN SCHIZOPHRENIC-PATIENTS - AN IDEA WHOSE TIME HAS COME
    MELTZER, HY
    ARCHIVES OF GENERAL PSYCHIATRY, 1995, 52 (03) : 200 - 202
  • [42] PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS
    HIETALA, J
    SYVALAHTI, E
    VUORIO, K
    RAKKOLAINEN, V
    BERGMAN, J
    HAAPARANTA, M
    SOLIN, O
    KUOPPAMAKI, M
    KIRVELA, O
    RUOTSALAINEN, U
    SALOKANGAS, RKR
    LANCET, 1995, 346 (8983): : 1130 - 1131
  • [43] DECREASED URINARY PEPTIDE EXCRETION IN SCHIZOPHRENIC-PATIENTS AFTER NEUROLEPTIC TREATMENT
    REICHELT, KL
    TEIGLANDGJERSTAD, B
    PSYCHIATRY RESEARCH, 1995, 58 (02) : 171 - 176
  • [44] DRUG LEVELS AND ANTIPARKINSONIAN DRUGS IN NEUROLEPTIC-TREATED SCHIZOPHRENIC-PATIENTS
    HITRI, A
    CRAFT, RB
    SETHI, R
    SINHA, D
    CLINICAL NEUROPHARMACOLOGY, 1987, 10 (03) : 261 - 271
  • [45] SERUM IRON ABNORMALITIES IN NEUROLEPTIC-INDUCED AKATHISIA IN SCHIZOPHRENIC-PATIENTS
    SONI, SD
    TENCH, D
    ROUTLEDGE, RC
    BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 : 669 - 672
  • [46] PLASMA-LEVELS OF NEUROLEPTIC DRUGS AND EXTRAPYRAMIDAL SYMPTOMS IN SCHIZOPHRENIC-PATIENTS
    BLOEINK, M
    BERGENER, M
    HESSE, C
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 833 - 833
  • [47] NEUROLEPTIC-INDUCED DECREASE IN PLATELET MAO ACTIVITY OF SCHIZOPHRENIC-PATIENTS
    CHOJNACKI, M
    KRALIK, P
    ALLEN, RH
    HO, BT
    SCHOOLAR, JC
    SMITH, RC
    AMERICAN JOURNAL OF PSYCHIATRY, 1981, 138 (06): : 838 - 840
  • [48] NEUROLEPTIC TREATMENT AND OTHER FACTORS MODIFYING CANCER RISK IN SCHIZOPHRENIC-PATIENTS
    RAVN, J
    ACTA PSYCHIATRICA SCANDINAVICA, 1987, 76 (05) : 605 - 605
  • [49] CELLULAR-IMMUNITY IN SCHIZOPHRENIC-PATIENTS BEFORE AND DURING NEUROLEPTIC TREATMENT
    MULLER, N
    ACKENHEIL, M
    HOFSCHUSTER, E
    MEMPEL, W
    ECKSTEIN, R
    PSYCHIATRY RESEARCH, 1991, 37 (02) : 147 - 160
  • [50] APOMORPHINE EFFECTS ON BRAIN METABOLISM IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS
    CLEGHORN, JM
    SZECHTMAN, H
    GARNETT, ES
    NAHMIAS, C
    BROWN, GM
    KAPLAN, RD
    SZECHTMAN, B
    FRANCO, S
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1991, 40 (02) : 135 - 153
12345